Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stifel Downgrades Applied Genetic Techs to Hold, Lowers Price Target to $0.34

Author: Benzinga Newsdesk | October 24, 2022 03:39pm
Stifel analyst Dae Gon Ha downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Hold and lowers the price target from $3 to $0.34.

Posted In: AGTC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist